Analytic Investors’s CDK Global, Inc. CDK Stock Holding History

Analytic Investors’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-49,049	Closed	-$2.33M	–	700
2015 Q4	$2.33M	Buy	+49,049	New	+$2.38M	0.03%	271

Other funds holding CDK

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Ridge Capital New York $215M AUM

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Analytic Investors's CDK Position: Q1 2016 in Review

Analytic Investors sold out of CDK Global, Inc. (CDK) in Q1 2016, closing a stake of 49,049 shares — an estimated $2.33M sold.

Analytic Investors first reported a position in CDK in Q4 2015 and held it in 1 quarter. The position peaked at $2.33M in Q4 2015. 502 funds tracked by Wall St. Rank hold CDK as of Q1 2016.

Analytic Investors reported no remaining CDK Global, Inc. position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 49,049 CDK Global, Inc. shares in Q1 2016, an estimated $2.33M.
Analytic Investors first reported a position in CDK Global, Inc. in Q4 2015 and held it in 1 quarter.
Analytic Investors's CDK Global, Inc. position peaked at $2.33M in Q4 2015.
502 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.